29:18

Autism Spectrum Disorder and Epilepsy –Part 2. Gregory Holmes, M.D. and Marvin Natowicz, M.D., Ph.D.

31:45

Autism Spectrum Disorder and Epilepsy – Case Studies

23:12

Autism Spectrum Disorder and Epilepsy – Part 1. Gregory Holmes, M.D. and Marvin Natowicz, M.D., Ph.D

01:03:07

Pain Management

43:27

Lupus: Advances in diagnosis and management

01:33:17

Optimizing outcomes in IMIDs: Focus on Co-Morbidities

01:53:49

Infections, COVID-19, Co-Morbidities with IMIDS

33:47

Are you treating your patient with AS and PsA effectively? The Learning Hub – Part II

56:09

Are you treating your patient with AS and PsA effectively? The Learning Hub – Part I

01:06:08

Rheumatoid Arthritis - Can we treat the disease and the patient?

01:18:40

Basic and Clinical Immunology for the Busy Clinician – Part II

01:14:46

Basic and Clinical Immunology for the Busy Clinician

01:11:29

Organ-specific issues in vasculitis

01:21:45

Current issues in ANCA associated vasculitis

54:41

CNS vasculitis

01:43:49

Key Issues in the Differential Diagnosis of Vasculitis

01:11:48

Wellness and Treating the COVID-19 Patient: Long term

01:41:16

COVID-19 and Rheumatologists/Clinical Immunologists

01:07:32

Old Diseases, New Developments

58:26

Old Diseases, New Treatments

01:44:23

Hot Topics in Immunology

01:06:17

Advances in Immunology for the Non-Immunologist: The human immune response at 30,000 feet

37:17

GLP-1 RA Therapy in T2D - Vinni Makin, MD, Kevin M. Pantalone, DO, Pratibha PR Rao, MD, MPH

36:59

Evidence-based Management of T2D with ASCVD, CKD, or HF

22:02

SGLT-2 Inhibitors- Vinni Makin, MD, Kevin M. Pantalone, DO, Pratibha PR Rao, MD, MPH

51:28

Rheum/Derm Overlap Diseases Immunologic Responses- Cassandra Calabrese, DO, Samantha Polly, MD

34:43

Rheum/Derm Overlap Diseases, IMIDs Involving the Skin- M. Elaine Husni, MD, MPH

01:23:18

Treatment of Psoriatic Disease

02:16:38

Update in Treatment Medical Dermatologic Diseases

01:54:50

Interprofessional Approach to Patients on Biologics with a Focus on Psoriatic Disease

21:29

Metabolic Interventions in PAH- Anna Hemnes, MD

21:54

Heterogeneity of Metabolic Endo-Phenotypes of PAH - Samar Farha, MD

22:22

PVDOMICs- Anna Hemnes, MD

19:14

Pulmonary Vascular Limitation After COVID: What is known so far?- Adriano Tonelli, MD

31:30

Chronic Thromboembolic PH- Alice Goyanes, MD

31:58

PH in ILD: Finally some hope?- Kristin Highland, MD

23:01

PH in HFpEF: What can we do?- Sanjeeb Bhattacharya, MD

21:07

Emerging Therapeutics for PAH- Bradley Maron, MD

23:45

Risk Stratification and Current Treatment Algorithm- Anthony R. Cucci, MD

25:27

Advances in the Diagnostic and Hemodynamic Evaluation of PH- Bradley Maron, MD

45:55

Gastrointestinal Issues in Autism Spectrum Disorders- Harland Winter, MD & Marvin Natowicz, MD, PhD

39:37

Improving Healthcare Access for Patients on the Autism Spectrum

44:45

Medical Challenges Associated with Autism and Aging- Margaret Bauman, MD & Marvin Natowicz, MD, PhD

23:40

MDSASH2020 Cases Panel

01:14

Cleveland Clinic Comprehensive COVID Care

41:05

Genetics and Autism Spectrum Disorder – Part One

37:40

Genetics and Autism Spectrum Disorder – Part Two

41:55

Psychiatric Issues and Autism Spectrum Disorder

45:45

Psychopharmacology and Autism Spectrum Disorder

01:30

Dr Vyas Evidence Based Medicine Promo 2019

03:52

Introduction to Obstructive Sleep Apnea: A Cleveland Clinic State-of-the-Art Review

02:45

Attend ASH Friday Satellite- Clinical Management of Myeloid Malignancies, November 30, San Diego

24:02

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

22:28

Update in Treatment of Psoriatic Arthritis

25:20

IL-17 Inhibitors

25:12

IL-12/23 Inhibitors and Small Molecule Inhibitors

22:44

TNF-Inhibitors: “Classic” Biologics for Psoriatic Disease

25:27

Update in Traditional Treatments (Topicals, UV Phototherapy, Systemics)

32:44

Targeted Treatment of Melanoma: Where Are We and Where Are We Going?

20:31

Update in Molecular Diagnostics for Cutaneous Malignancies